Mineral metabolism in chronic renal failure with special reference to serum concentrations of 1.25(OH)2D and 24.25(OH)2D. 1981

C Christiansen, and M S Christensen, and F Melsen, and P Rødbro, and H F DeLuca

This study examines the interrelationship between serum levels of substances important in mineral metabolism including the 3 vitamin D metabolites 25OHD, 24.25(OH)2D and 1.25(OH)2D and static and dynamic histomorphometric measurements of bone remodelling in iliac crest biopsies in 17 patients with chronic renal failure. No correlation was found between the serum values of any of the vitamin D metabolites and the histomorphometric values. However, significant inverse correlations were found between serum calcium and both the osteoid surface extent (P less than 0.05) and osteoid volume (P less than 0.05) in trabecular bone. Serum immunoreactive parathyroid hormone (iPTH) was positively related to trabecular osteoclastic bone resorption. The serum level of 1.25(OH)2D was inversely related to endogenous creatinine clearance (P less than 0.01). These results support the hypothesis that the serum calcium concentration is more important than the serum concentration of vitamin D metabolites for bone remodelling in chronic renal failure.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008903 Minerals Native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions. They may occur as individual crystals or may be disseminated in some other mineral or rock. (Grant & Hackh's Chemical Dictionary, 5th ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Mineral
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D004100 Dihydroxycholecalciferols Cholecalciferols substituted with two hydroxy groups in any position. Dihydroxyvitamins D
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006887 Hydroxycholecalciferols Hydroxy analogs of vitamin D 3; (CHOLECALCIFEROL); including CALCIFEDIOL; CALCITRIOL; and 24,25-DIHYDROXYVITAMIN D 3. Hydroxyvitamins D,Hydroxycholecalciferol

Related Publications

C Christiansen, and M S Christensen, and F Melsen, and P Rødbro, and H F DeLuca
September 1996, The Tohoku journal of experimental medicine,
C Christiansen, and M S Christensen, and F Melsen, and P Rødbro, and H F DeLuca
October 1995, Nihon Jinzo Gakkai shi,
C Christiansen, and M S Christensen, and F Melsen, and P Rødbro, and H F DeLuca
April 1991, Transplantation proceedings,
C Christiansen, and M S Christensen, and F Melsen, and P Rødbro, and H F DeLuca
June 1991, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
C Christiansen, and M S Christensen, and F Melsen, and P Rødbro, and H F DeLuca
April 1970, The British journal of radiology,
C Christiansen, and M S Christensen, and F Melsen, and P Rødbro, and H F DeLuca
November 1986, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
C Christiansen, and M S Christensen, and F Melsen, and P Rødbro, and H F DeLuca
June 2008, Reviews in endocrine & metabolic disorders,
C Christiansen, and M S Christensen, and F Melsen, and P Rødbro, and H F DeLuca
January 1978, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,
C Christiansen, and M S Christensen, and F Melsen, and P Rødbro, and H F DeLuca
June 1961, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
C Christiansen, and M S Christensen, and F Melsen, and P Rødbro, and H F DeLuca
March 1985, Kidney international,
Copied contents to your clipboard!